Evoke Pharma Stock Volatility
| EVOK Stock | USD 4.33 0.17 3.78% |
As of now, Evoke Stock is very risky. Evoke Pharma secures Sharpe Ratio (or Efficiency) of 0.0122, which denotes the company had a 0.0122% return per unit of risk over the last 3 months. We have found twenty-eight technical indicators for Evoke Pharma, which you can use to evaluate the volatility of the firm. Please confirm Evoke Pharma's Coefficient Of Variation of 9457.88, downside deviation of 5.0, and Mean Deviation of 3.99 to check if the risk estimate we provide is consistent with the expected return of 0.0774%. Key indicators related to Evoke Pharma's volatility include:
30 Days Market Risk | Chance Of Distress | 30 Days Economic Sensitivity |
Evoke Pharma Stock volatility depicts how high the prices fluctuate around the mean (or its average) price. In other words, it is a statistical measure of the distribution of Evoke daily returns, and it is calculated using variance and standard deviation. We also use Evoke's beta, its sensitivity to the market, as well as its odds of financial distress to provide a more practical estimation of Evoke Pharma volatility.
Evoke |
ESG Sustainability
While most ESG disclosures are voluntary, Evoke Pharma's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Evoke Pharma's managers and investors.Environmental | Governance | Social |
Downward market volatility can be a perfect environment for investors who play the long game. Here, they may decide to buy additional stocks of Evoke Pharma at lower prices. For example, an investor can purchase Evoke stock that has halved in price over a short period. This will lower their average cost per share, thereby improving the overall portfolio performance when market normalizes.
Moving together with Evoke Stock
Moving against Evoke Stock
| 0.63 | VCNX | Vaccinex | PairCorr |
| 0.58 | FBRX | Forte Biosciences Trending | PairCorr |
| 0.55 | GMAB | Genmab AS | PairCorr |
| 0.49 | KRYS | Krystal Biotech | PairCorr |
| 0.48 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
| 0.42 | LEGN | Legend Biotech Corp | PairCorr |
| 0.39 | NRSNW | NeuroSense Therapeutics | PairCorr |
| 0.38 | IPSC | Century Therapeutics | PairCorr |
| 0.36 | VALN | Valneva SE ADR | PairCorr |
Evoke Pharma Market Sensitivity And Downside Risk
Evoke Pharma's beta coefficient measures the volatility of Evoke stock compared to the systematic risk of the entire market represented by your selected benchmark. In mathematical terms, beta represents the slope of the line through a regression of data points where each of these points represents Evoke stock's returns against your selected market. In other words, Evoke Pharma's beta of 1.46 provides an investor with an approximation of how much risk Evoke Pharma stock can potentially add to one of your existing portfolios. Evoke Pharma is displaying above-average volatility over the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Evoke Pharma's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Evoke Pharma's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.
3 Months Beta |Analyze Evoke Pharma Demand TrendCheck current 90 days Evoke Pharma correlation with market (Dow Jones Industrial)Evoke Beta |
Evoke standard deviation measures the daily dispersion of prices over your selected time horizon relative to its mean. A typical volatile entity has a high standard deviation, while the deviation of a stable instrument is usually low. As a downside, the standard deviation calculates all uncertainty as risk, even when it is in your favor, such as above-average returns.
Standard Deviation | 6.32 |
It is essential to understand the difference between upside risk (as represented by Evoke Pharma's standard deviation) and the downside risk, which can be measured by semi-deviation or downside deviation of Evoke Pharma's daily returns or price. Since the actual investment returns on holding a position in evoke stock tend to have a non-normal distribution, there will be different probabilities for losses than for gains. The likelihood of losses is reflected in the downside risk of an investment in Evoke Pharma.
Evoke Pharma Stock Volatility Analysis
Volatility refers to the frequency at which Evoke Pharma stock price increases or decreases within a specified period. These fluctuations usually indicate the level of risk that's associated with Evoke Pharma's price changes. Investors will then calculate the volatility of Evoke Pharma's stock to predict their future moves. A stock that has erratic price changes quickly hits new highs, and lows are considered highly volatile. A stock with relatively stable price changes has low volatility. A highly volatile stock is riskier, but the risk cuts both ways. Investing in highly volatile security can either be highly successful, or you may experience significant failure. There are two main types of Evoke Pharma's volatility:
Historical Volatility
This type of stock volatility measures Evoke Pharma's fluctuations based on previous trends. It's commonly used to predict Evoke Pharma's future behavior based on its past. However, it cannot conclusively determine the future direction of the stock.Implied Volatility
This type of volatility provides a positive outlook on future price fluctuations for Evoke Pharma's current market price. This means that the stock will return to its initially predicted market price. This type of volatility can be derived from derivative instruments written on Evoke Pharma's to be redeemed at a future date.Transformation |
The output start index for this execution was zero with a total number of output elements of sixty-one. Evoke Pharma Average Price is the average of the sum of open, high, low and close daily prices of a bar. It can be used to smooth an indicator that normally takes just the closing price as input.
Evoke Pharma Projected Return Density Against Market
Given the investment horizon of 90 days the stock has the beta coefficient of 1.4586 suggesting as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, Evoke Pharma will likely underperform.Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Evoke Pharma or Pharmaceuticals sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Evoke Pharma's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Evoke stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
Evoke Pharma has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Predicted Return Density |
| Returns |
What Drives an Evoke Pharma Price Volatility?
Several factors can influence a stock's market volatility:Industry
Specific events can influence volatility within a particular industry. For instance, a significant weather upheaval in a crucial oil-production site may cause oil prices to increase in the oil sector. The direct result will be the rise in the stock price of oil distribution companies. Similarly, any government regulation in a specific industry could negatively influence stock prices due to increased regulations on compliance that may impact the company's future earnings and growth.Political and Economic environment
When governments make significant decisions regarding trade agreements, policies, and legislation regarding specific industries, they will influence stock prices. Everything from speeches to elections may influence investors, who can directly influence the stock prices in any particular industry. The prevailing economic situation also plays a significant role in stock prices. When the economy is doing well, investors will have a positive reaction and hence, better stock prices and vice versa.The Company's Performance
Sometimes volatility will only affect an individual company. For example, a revolutionary product launch or strong earnings report may attract many investors to purchase the company. This positive attention will raise the company's stock price. In contrast, product recalls and data breaches may negatively influence a company's stock prices.Evoke Pharma Stock Risk Measures
Given the investment horizon of 90 days the coefficient of variation of Evoke Pharma is 8169.71. The daily returns are distributed with a variance of 39.96 and standard deviation of 6.32. The mean deviation of Evoke Pharma is currently at 3.95. For similar time horizon, the selected benchmark (Dow Jones Industrial) has volatility of 0.76
α | Alpha over Dow Jones | -0.09 | |
β | Beta against Dow Jones | 1.46 | |
σ | Overall volatility | 6.32 | |
Ir | Information ratio | -0.0067 |
Evoke Pharma Stock Return Volatility
Evoke Pharma historical daily return volatility represents how much of Evoke Pharma stock's daily returns swing around its mean - it is a statistical measure of its dispersion of returns. The company inherits 6.3217% risk (volatility on return distribution) over the 90 days horizon. By contrast, Dow Jones Industrial accepts 0.7685% volatility on return distribution over the 90 days horizon. Performance |
| Timeline |
About Evoke Pharma Volatility
Volatility is a rate at which the price of Evoke Pharma or any other equity instrument increases or decreases for a given set of returns. It is measured by calculating the standard deviation of the annualized returns over a given period of time and shows the range to which the price of Evoke Pharma may increase or decrease. In other words, similar to Evoke's beta indicator, it measures the risk of Evoke Pharma and helps estimate the fluctuations that may happen in a short period of time. So if prices of Evoke Pharma fluctuate rapidly in a short time span, it is termed to have high volatility, and if it swings slowly in a more extended period, it is understood to have low volatility.
Please read more on our technical analysis page.| Last Reported | Projected for Next Year | ||
| Market Cap | 3.5 M | 3.3 M |
Evoke Pharma's stock volatility refers to the amount of uncertainty or risk involved with the size of changes in its stock's price. It is a statistical measure of the dispersion of returns on Evoke Stock over a specified period of time, often expressed as the standard deviation of daily returns. In other words, it measures how much Evoke Pharma's price varies over time.
3 ways to utilize Evoke Pharma's volatility to invest better
Higher Evoke Pharma's stock volatility means that the price of its stock is changing rapidly and unpredictably, while lower stock volatility indicates that the price of Evoke Pharma stock is relatively stable. Investors and traders use stock volatility as an indicator of risk and potential reward, as stocks with higher volatility can offer the potential for more significant returns but also come with a greater risk of losses. Evoke Pharma stock volatility can provide helpful information for making investment decisions in the following ways:- Measuring Risk: Volatility can be used as a measure of risk, which can help you determine the potential fluctuations in the value of Evoke Pharma investment. A higher volatility means higher risk and potentially larger changes in value.
- Identifying Opportunities: High volatility in Evoke Pharma's stock can indicate that there is potential for significant price movements, either up or down, which could present investment opportunities.
- Diversification: Understanding how the volatility of Evoke Pharma's stock relates to your other investments can help you create a well-diversified portfolio of assets with varying levels of risk.
Evoke Pharma Investment Opportunity
Evoke Pharma has a volatility of 6.32 and is 8.21 times more volatile than Dow Jones Industrial. 56 percent of all equities and portfolios are less risky than Evoke Pharma. You can use Evoke Pharma to protect your portfolios against small market fluctuations. The stock experiences an unexpected downward movement. The market is reacting to new fundamentals. Check odds of Evoke Pharma to be traded at $4.16 in 90 days.Average diversification
The correlation between Evoke Pharma and DJI is 0.18 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Evoke Pharma and DJI in the same portfolio, assuming nothing else is changed.
Evoke Pharma Additional Risk Indicators
The analysis of Evoke Pharma's secondary risk indicators is one of the essential steps in making a buy or sell decision. The process involves identifying the amount of risk involved in Evoke Pharma's investment and either accepting that risk or mitigating it. Along with some common measures of Evoke Pharma stock's risk such as standard deviation, beta, or value at risk, we also provide a set of secondary indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Risk Adjusted Performance | 0.0169 | |||
| Market Risk Adjusted Performance | 0.0491 | |||
| Mean Deviation | 3.99 | |||
| Semi Deviation | 4.79 | |||
| Downside Deviation | 5.0 | |||
| Coefficient Of Variation | 9457.88 | |||
| Standard Deviation | 6.33 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential stocks, we recommend comparing similar stocks with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Evoke Pharma Suggested Diversification Pairs
Pair trading is one of the very effective strategies used by professional day traders and hedge funds capitalizing on short-time and mid-term market inefficiencies. The approach is based on the fact that the ratio of prices of two correlating shares is long-term stable and oscillates around the average value. If the correlation ratio comes outside the common area, you can speculate with a high success rate that the ratio will return to the mean value and collect a profit.
The effect of pair diversification on risk is to reduce it, but we should note this doesn't apply to all risk types. When we trade pairs against Evoke Pharma as a counterpart, there is always some inherent risk that will never be diversified away no matter what. This volatility limits the effect of tactical diversification using pair trading. Evoke Pharma's systematic risk is the inherent uncertainty of the entire market, and therefore cannot be mitigated even by pair-trading it against the equity that is not highly correlated to it. On the other hand, Evoke Pharma's unsystematic risk describes the types of risk that we can protect against, at least to some degree, by selecting a matching pair that is not perfectly correlated to Evoke Pharma.
When determining whether Evoke Pharma is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Evoke Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Evoke Pharma Stock. Highlighted below are key reports to facilitate an investment decision about Evoke Pharma Stock: Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Evoke Pharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. For more information on how to buy Evoke Stock please use our How to buy in Evoke Stock guide.You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Evoke Pharma. If investors know Evoke will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Evoke Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (10.13) | Revenue Per Share 7.792 | Quarterly Revenue Growth 0.698 | Return On Assets (0.34) | Return On Equity (3.50) |
The market value of Evoke Pharma is measured differently than its book value, which is the value of Evoke that is recorded on the company's balance sheet. Investors also form their own opinion of Evoke Pharma's value that differs from its market value or its book value, called intrinsic value, which is Evoke Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Evoke Pharma's market value can be influenced by many factors that don't directly affect Evoke Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Evoke Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Evoke Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Evoke Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.